| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | adenylate cyclase regulator activity | 1.80e-07 | 9 | 125 | 4 | GO:0010854 | |
| GeneOntologyMolecularFunction | adenylate cyclase activator activity | 2.37e-06 | 5 | 125 | 3 | GO:0010856 | |
| GeneOntologyMolecularFunction | cyclase regulator activity | 4.18e-06 | 18 | 125 | 4 | GO:0010851 | |
| GeneOntologyMolecularFunction | type 3 metabotropic glutamate receptor binding | 4.72e-06 | 6 | 125 | 3 | GO:0031800 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase regulator activity | 2.78e-05 | 10 | 125 | 3 | GO:0030235 | |
| GeneOntologyMolecularFunction | formyltetrahydrofolate dehydrogenase activity | 3.89e-05 | 2 | 125 | 2 | GO:0016155 | |
| GeneOntologyMolecularFunction | protein phosphatase regulator activity | 3.93e-05 | 100 | 125 | 6 | GO:0019888 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | CAB39 CALM1 CALM2 CALM3 RALGAPB ARHGEF12 HMGCR ADGRV1 SOCS6 DENND4C SH3PXD2B SERPINA4 SERPINB8 SAG DENND10 DLC1 PPP3R2 TIAM1 SPOCK3 BCL2L13 FGD3 PPP6R3 | 6.48e-05 | 1418 | 125 | 22 | GO:0030234 |
| GeneOntologyMolecularFunction | cyclase activator activity | 6.54e-05 | 13 | 125 | 3 | GO:0010853 | |
| GeneOntologyMolecularFunction | phosphatase regulator activity | 7.80e-05 | 113 | 125 | 6 | GO:0019208 | |
| GeneOntologyMolecularFunction | titin binding | 8.29e-05 | 14 | 125 | 3 | GO:0031432 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase (NAD+) activity | 1.03e-04 | 15 | 125 | 3 | GO:0004029 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor binding | 1.26e-04 | 16 | 125 | 3 | GO:0035256 | |
| GeneOntologyMolecularFunction | neurexin family protein binding | 1.26e-04 | 16 | 125 | 3 | GO:0042043 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 1.26e-04 | 16 | 125 | 3 | GO:0008179 | |
| GeneOntologyMolecularFunction | protein phosphatase activator activity | 1.53e-04 | 17 | 125 | 3 | GO:0072542 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase [NAD(P)+] activity | 1.53e-04 | 17 | 125 | 3 | GO:0004030 | |
| GeneOntologyMolecularFunction | phosphatase activator activity | 2.53e-04 | 20 | 125 | 3 | GO:0019211 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 3.38e-04 | 22 | 125 | 3 | GO:0050998 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 4.18e-04 | 56 | 125 | 4 | GO:0016903 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 1.46e-03 | 78 | 125 | 4 | GO:0043539 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 1.68e-03 | 81 | 125 | 4 | GO:0035254 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 2.46e-03 | 43 | 125 | 3 | GO:0043548 | |
| GeneOntologyBiologicalProcess | positive regulation of ryanodine-sensitive calcium-release channel activity | 1.58e-07 | 9 | 125 | 4 | GO:0060316 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclic-nucleotide phosphodiesterase activity | 2.17e-07 | 3 | 125 | 3 | GO:0051343 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion export across plasma membrane | 2.15e-06 | 5 | 125 | 3 | GO:1905913 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion export across plasma membrane | 4.29e-06 | 6 | 125 | 3 | GO:1905912 | |
| GeneOntologyBiologicalProcess | regulation of cyclic-nucleotide phosphodiesterase activity | 4.29e-06 | 6 | 125 | 3 | GO:0051342 | |
| GeneOntologyBiologicalProcess | negative regulation of high voltage-gated calcium channel activity | 1.19e-05 | 8 | 125 | 3 | GO:1901842 | |
| GeneOntologyBiologicalProcess | regulation of ryanodine-sensitive calcium-release channel activity | 1.73e-05 | 26 | 125 | 4 | GO:0060314 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transporter activity | 2.65e-05 | 256 | 125 | 9 | GO:0032412 | |
| GeneOntologyBiologicalProcess | negative regulation of ryanodine-sensitive calcium-release channel activity | 3.46e-05 | 11 | 125 | 3 | GO:0060315 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphatase activity | 3.56e-05 | 31 | 125 | 4 | GO:0010922 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane transporter activity | 3.58e-05 | 266 | 125 | 9 | GO:0022898 | |
| GeneOntologyBiologicalProcess | positive regulation of dephosphorylation | 3.70e-05 | 62 | 125 | 5 | GO:0035306 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-threonine phosphorylation | 4.05e-05 | 32 | 125 | 4 | GO:0010800 | |
| GeneOntologyBiologicalProcess | calcium ion export across plasma membrane | 4.59e-05 | 12 | 125 | 3 | GO:1990034 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling involved in cardiac conduction | 4.59e-05 | 12 | 125 | 3 | GO:1901844 | |
| GeneOntologyBiologicalProcess | detection of calcium ion | 5.94e-05 | 13 | 125 | 3 | GO:0005513 | |
| GeneOntologyBiologicalProcess | regulation of phosphatase activity | 8.70e-05 | 74 | 125 | 5 | GO:0010921 | |
| GeneOntologyBiologicalProcess | regulation of transporter activity | 8.82e-05 | 299 | 125 | 9 | GO:0032409 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transporter activity | 8.97e-05 | 39 | 125 | 4 | GO:1901021 | |
| GeneOntologyBiologicalProcess | 10-formyltetrahydrofolate catabolic process | 1.09e-04 | 3 | 125 | 2 | GO:0009258 | |
| GeneOntologyBiologicalProcess | regulation of high voltage-gated calcium channel activity | 1.15e-04 | 16 | 125 | 3 | GO:1901841 | |
| GeneOntologyBiologicalProcess | regulation of dephosphorylation | 1.30e-04 | 128 | 125 | 6 | GO:0035303 | |
| GeneOntologyBiologicalProcess | negative regulation of release of sequestered calcium ion into cytosol | 1.39e-04 | 17 | 125 | 3 | GO:0051280 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling | 1.66e-04 | 18 | 125 | 3 | GO:0010649 | |
| GeneOntologyBiologicalProcess | protein dephosphorylation | 1.70e-04 | 256 | 125 | 8 | GO:0006470 | |
| GeneOntologyBiologicalProcess | positive regulation of sequestering of calcium ion | 1.96e-04 | 19 | 125 | 3 | GO:0051284 | |
| GeneOntologyBiologicalProcess | positive regulation of release of sequestered calcium ion into cytosol | 2.03e-04 | 48 | 125 | 4 | GO:0051281 | |
| GeneOntologyBiologicalProcess | negative regulation of voltage-gated calcium channel activity | 2.67e-04 | 21 | 125 | 3 | GO:1901386 | |
| GeneOntologyBiologicalProcess | dephosphorylation | 2.69e-04 | 347 | 125 | 9 | GO:0016311 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-threonine phosphorylation | 2.78e-04 | 52 | 125 | 4 | GO:0010799 | |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | CALM1 RHBDF2 CALM2 CALM3 RALGAPB SERPINA4 SERPINB8 DLC1 TIAM1 SPOCK3 CHP2 CD44 BCL2L13 FGD3 PPP6R3 | 2.79e-04 | 878 | 125 | 15 | GO:0051336 |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 3.08e-04 | 22 | 125 | 3 | GO:0010881 | |
| GeneOntologyBiologicalProcess | positive regulation of ion transmembrane transporter activity | 3.11e-04 | 97 | 125 | 5 | GO:0032414 | |
| GeneOntologyBiologicalProcess | positive regulation of cation channel activity | 3.70e-04 | 56 | 125 | 4 | GO:2001259 | |
| GeneOntologyBiologicalProcess | presynaptic endocytosis | 3.93e-04 | 102 | 125 | 5 | GO:0140238 | |
| GeneOntologyBiologicalProcess | negative regulation of peptidyl-threonine phosphorylation | 4.01e-04 | 24 | 125 | 3 | GO:0010801 | |
| GeneOntologyBiologicalProcess | response to calcium ion | 4.50e-04 | 161 | 125 | 6 | GO:0051592 | |
| GeneOntologyBiologicalProcess | NADPH regeneration | 4.53e-04 | 25 | 125 | 3 | GO:0006740 | |
| GeneOntologyBiologicalProcess | positive regulation of transporter activity | 4.90e-04 | 107 | 125 | 5 | GO:0032411 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling involved in cardiac conduction | 5.10e-04 | 26 | 125 | 3 | GO:0086064 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport | 5.33e-04 | 109 | 125 | 5 | GO:1904427 | |
| GeneOntologyBiologicalProcess | 10-formyltetrahydrofolate metabolic process | 5.38e-04 | 6 | 125 | 2 | GO:0009256 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by calcium ion signaling | 6.37e-04 | 28 | 125 | 3 | GO:0010882 | |
| GeneOntologyBiologicalProcess | positive regulation of cation transmembrane transport | 6.77e-04 | 174 | 125 | 6 | GO:1904064 | |
| GeneOntologyBiologicalProcess | negative regulation of cation transmembrane transport | 7.07e-04 | 116 | 125 | 5 | GO:1904063 | |
| GeneOntologyBiologicalProcess | positive regulation of protein autophosphorylation | 7.08e-04 | 29 | 125 | 3 | GO:0031954 | |
| GeneOntologyBiologicalProcess | sperm mitochondrion organization | 7.50e-04 | 7 | 125 | 2 | GO:0030382 | |
| GeneOntologyBiologicalProcess | folic acid-containing compound catabolic process | 7.50e-04 | 7 | 125 | 2 | GO:0009397 | |
| GeneOntologyBiologicalProcess | pteridine-containing compound catabolic process | 7.50e-04 | 7 | 125 | 2 | GO:0042560 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell action potential | 7.83e-04 | 30 | 125 | 3 | GO:0098901 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transmembrane transport | 8.20e-04 | 69 | 125 | 4 | GO:1903170 | |
| GeneOntologyBiologicalProcess | regulation of calcium-mediated signaling | 8.56e-04 | 121 | 125 | 5 | GO:0050848 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane transport | CAB39 CALM1 CALM2 CALM3 CALML3 ITLN1 NLGN1 PPP3R2 NETO1 CHP2 NLGN2 | 9.22e-04 | 589 | 125 | 11 | GO:0034762 |
| GeneOntologyBiologicalProcess | negative regulation of monoatomic ion transmembrane transport | 9.56e-04 | 124 | 125 | 5 | GO:0034766 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to synapse | 9.96e-04 | 8 | 125 | 2 | GO:1902474 | |
| GeneOntologyBiologicalProcess | positive regulation of Schwann cell migration | 9.96e-04 | 8 | 125 | 2 | GO:1900149 | |
| GeneOntologyBiologicalProcess | autophagosome membrane docking | 9.96e-04 | 8 | 125 | 2 | GO:0016240 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle clustering | 9.96e-04 | 8 | 125 | 2 | GO:2000809 | |
| GeneOntologyBiologicalProcess | presynapse organization | 1.01e-03 | 73 | 125 | 4 | GO:0099172 | |
| GeneOntologyBiologicalProcess | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 1.04e-03 | 33 | 125 | 3 | GO:0010880 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transmembrane transport | 1.13e-03 | 192 | 125 | 6 | GO:0034767 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | 1.20e-03 | 266 | 125 | 7 | GO:0043270 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling | 1.23e-03 | 35 | 125 | 3 | GO:0010644 | |
| GeneOntologyBiologicalProcess | terminal button organization | 1.28e-03 | 9 | 125 | 2 | GO:0072553 | |
| GeneOntologyBiologicalProcess | positive regulation of hematopoietic progenitor cell differentiation | 1.28e-03 | 9 | 125 | 2 | GO:1901534 | |
| GeneOntologyBiologicalProcess | mitochondrion-endoplasmic reticulum membrane tethering | 1.28e-03 | 9 | 125 | 2 | GO:1990456 | |
| GeneOntologyCellularComponent | sperm midpiece | 2.29e-06 | 64 | 125 | 6 | GO:0097225 | |
| HumanPheno | Polymorphic ventricular tachycardia | 3.76e-05 | 10 | 36 | 3 | HP:0031677 | |
| HumanPheno | Aplasia of the nose | 4.86e-05 | 2 | 36 | 2 | HP:0009927 | |
| HumanPheno | 2:1 atrioventricular block | 4.86e-05 | 2 | 36 | 2 | HP:0034305 | |
| Domain | 10_FTHF_DH | 4.30e-05 | 2 | 123 | 2 | IPR011407 | |
| Domain | - | 1.29e-04 | 3 | 123 | 2 | 3.10.25.10 | |
| Domain | GART_AS | 1.29e-04 | 3 | 123 | 2 | IPR001555 | |
| Domain | Formyl_trans_C | 1.29e-04 | 3 | 123 | 2 | PF02911 | |
| Domain | Formyl_trans_C | 1.29e-04 | 3 | 123 | 2 | IPR005793 | |
| Domain | GART | 1.29e-04 | 3 | 123 | 2 | PS00373 | |
| Domain | Ald_DH_CS_GLU | 1.47e-04 | 16 | 123 | 3 | IPR029510 | |
| Domain | Ald_DH_CS_CYS | 1.77e-04 | 17 | 123 | 3 | IPR016160 | |
| Domain | ALDEHYDE_DEHYDR_CYS | 2.12e-04 | 18 | 123 | 3 | PS00070 | |
| Domain | ALDEHYDE_DEHYDR_GLU | 2.12e-04 | 18 | 123 | 3 | PS00687 | |
| Domain | EF-hand_7 | 2.46e-04 | 85 | 123 | 5 | PF13499 | |
| Domain | - | 2.50e-04 | 19 | 123 | 3 | 3.40.605.10 | |
| Domain | Aldedh | 2.50e-04 | 19 | 123 | 3 | PF00171 | |
| Domain | Ald_DH_C | 2.50e-04 | 19 | 123 | 3 | IPR016163 | |
| Domain | Ald_DH_N | 2.50e-04 | 19 | 123 | 3 | IPR016162 | |
| Domain | Ald_DH/histidinol_DH | 2.50e-04 | 19 | 123 | 3 | IPR016161 | |
| Domain | Aldehyde_DH_dom | 2.50e-04 | 19 | 123 | 3 | IPR015590 | |
| Domain | - | 2.50e-04 | 19 | 123 | 3 | 3.40.309.10 | |
| Domain | - | 2.56e-04 | 4 | 123 | 2 | 3.40.50.170 | |
| Domain | Formyl_transf_N | 2.56e-04 | 4 | 123 | 2 | IPR002376 | |
| Domain | Formyl_trans_N | 2.56e-04 | 4 | 123 | 2 | PF00551 | |
| Domain | - | 2.93e-04 | 20 | 123 | 3 | 3.30.565.10 | |
| Domain | HATPase_C | 3.40e-04 | 21 | 123 | 3 | IPR003594 | |
| Domain | ARM-type_fold | 4.13e-04 | 339 | 123 | 9 | IPR016024 | |
| Domain | FtsJ | 4.25e-04 | 5 | 123 | 2 | PF01728 | |
| Domain | - | 4.25e-04 | 5 | 123 | 2 | 1.10.1200.10 | |
| Domain | PHOSPHOPANTETHEINE | 4.25e-04 | 5 | 123 | 2 | PS00012 | |
| Domain | Formyl_transferase_C-like | 4.25e-04 | 5 | 123 | 2 | IPR011034 | |
| Domain | Nlgn | 4.25e-04 | 5 | 123 | 2 | IPR000460 | |
| Domain | rRNA_MeTrfase_FtsJ_dom | 4.25e-04 | 5 | 123 | 2 | IPR002877 | |
| Domain | PP-binding | 4.25e-04 | 5 | 123 | 2 | PF00550 | |
| Domain | ACP_DOMAIN | 4.25e-04 | 5 | 123 | 2 | PS50075 | |
| Domain | EF-hand_1 | 5.11e-04 | 152 | 123 | 6 | PF00036 | |
| Domain | EFh | 6.27e-04 | 158 | 123 | 6 | SM00054 | |
| Domain | EF-hand-dom_pair | 6.32e-04 | 287 | 123 | 8 | IPR011992 | |
| Domain | EPTP | 6.34e-04 | 6 | 123 | 2 | PF03736 | |
| Domain | EPTP | 6.34e-04 | 6 | 123 | 2 | IPR005492 | |
| Domain | PP-bd_ACP | 6.34e-04 | 6 | 123 | 2 | IPR009081 | |
| Domain | EAR | 8.84e-04 | 7 | 123 | 2 | IPR009039 | |
| Domain | EAR | 8.84e-04 | 7 | 123 | 2 | PS50912 | |
| Domain | EF_Hand_1_Ca_BS | 1.07e-03 | 175 | 123 | 6 | IPR018247 | |
| Domain | - | 1.72e-03 | 261 | 123 | 7 | 1.10.238.10 | |
| Domain | EF_HAND_1 | 2.33e-03 | 204 | 123 | 6 | PS00018 | |
| Domain | PX | 3.03e-03 | 44 | 123 | 3 | SM00312 | |
| Domain | Carboxylesterase_B_CS | 3.20e-03 | 13 | 123 | 2 | IPR019819 | |
| Domain | CARBOXYLESTERASE_B_2 | 3.72e-03 | 14 | 123 | 2 | PS00941 | |
| Domain | COesterase | 3.72e-03 | 14 | 123 | 2 | PF00135 | |
| Domain | - | 3.72e-03 | 14 | 123 | 2 | 2.60.40.1180 | |
| Domain | CarbesteraseB | 3.72e-03 | 14 | 123 | 2 | IPR002018 | |
| Domain | PX | 4.12e-03 | 49 | 123 | 3 | PF00787 | |
| Domain | START_lipid-bd_dom | 4.27e-03 | 15 | 123 | 2 | IPR002913 | |
| Domain | FH2 | 4.27e-03 | 15 | 123 | 2 | PS51444 | |
| Domain | FH2_Formin | 4.27e-03 | 15 | 123 | 2 | IPR015425 | |
| Domain | FH2 | 4.27e-03 | 15 | 123 | 2 | PF02181 | |
| Domain | START | 4.27e-03 | 15 | 123 | 2 | PF01852 | |
| Domain | Glyco_hydro_b | 4.27e-03 | 15 | 123 | 2 | IPR013780 | |
| Domain | START | 4.27e-03 | 15 | 123 | 2 | PS50848 | |
| Domain | FH2 | 4.27e-03 | 15 | 123 | 2 | SM00498 | |
| Domain | EF_HAND_2 | 4.29e-03 | 231 | 123 | 6 | PS50222 | |
| Domain | PX | 4.36e-03 | 50 | 123 | 3 | PS50195 | |
| Domain | EF_hand_dom | 4.38e-03 | 232 | 123 | 6 | IPR002048 | |
| Domain | - | 4.61e-03 | 51 | 123 | 3 | 3.30.1520.10 | |
| Domain | Phox | 4.87e-03 | 52 | 123 | 3 | IPR001683 | |
| Domain | Gal_mutarotase_SF_dom | 5.48e-03 | 17 | 123 | 2 | IPR011013 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LYSOSOMAL_CA2_RELEASE | 3.03e-07 | 10 | 89 | 4 | M47954 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CN_SIGNALING_PATHWAY | 7.07e-07 | 12 | 89 | 4 | M47956 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 2.41e-06 | 5 | 89 | 3 | MM14493 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 2.55e-06 | 16 | 89 | 4 | M47449 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN | 3.32e-06 | 17 | 89 | 4 | M47560 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 4.25e-06 | 18 | 89 | 4 | M47580 | |
| Pathway | REACTOME_CAM_PDE_1_ACTIVATION | 4.80e-06 | 6 | 89 | 3 | MM14494 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS | 4.80e-06 | 6 | 89 | 3 | MM15662 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 5.06e-06 | 70 | 89 | 6 | M3115 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 5.35e-06 | 19 | 89 | 4 | M47543 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 8.18e-06 | 21 | 89 | 4 | M47542 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 8.36e-06 | 7 | 89 | 3 | MM1357 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 1.99e-05 | 9 | 89 | 3 | M3412 | |
| Pathway | BIOCARTA_NO1_PATHWAY | 2.71e-05 | 28 | 89 | 4 | M4383 | |
| Pathway | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | 2.83e-05 | 10 | 89 | 3 | MM14570 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 3.12e-05 | 29 | 89 | 4 | MM15219 | |
| Pathway | REACTOME_CALCINEURIN_ACTIVATES_NFAT | 3.87e-05 | 11 | 89 | 3 | MM14810 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 3.87e-05 | 11 | 89 | 3 | M47958 | |
| Pathway | REACTOME_THE_PHOTOTRANSDUCTION_CASCADE | 4.10e-05 | 31 | 89 | 4 | MM14896 | |
| Pathway | REACTOME_ENOS_ACTIVATION | 5.14e-05 | 12 | 89 | 3 | MM14817 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 5.14e-05 | 12 | 89 | 3 | MM15142 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 6.65e-05 | 13 | 89 | 3 | MM15078 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 7.86e-05 | 113 | 89 | 6 | M16817 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 8.42e-05 | 14 | 89 | 3 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 8.42e-05 | 14 | 89 | 3 | M47388 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 8.42e-05 | 14 | 89 | 3 | MM15052 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 8.42e-05 | 14 | 89 | 3 | MM1473 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 8.42e-05 | 14 | 89 | 3 | MM15391 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 1.05e-04 | 15 | 89 | 3 | M47385 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 1.05e-04 | 15 | 89 | 3 | M15181 | |
| Pathway | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | 1.05e-04 | 15 | 89 | 3 | MM15103 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 1.05e-04 | 15 | 89 | 3 | MM1387 | |
| Pathway | REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION | 1.05e-04 | 15 | 89 | 3 | MM14795 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.28e-04 | 16 | 89 | 3 | MM14492 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 1.28e-04 | 16 | 89 | 3 | MM1483 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 1.55e-04 | 17 | 89 | 3 | M10066 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 1.55e-04 | 17 | 89 | 3 | M47387 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 1.55e-04 | 17 | 89 | 3 | M5940 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 1.55e-04 | 17 | 89 | 3 | MM1372 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 1.55e-04 | 17 | 89 | 3 | M2349 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 1.66e-04 | 44 | 89 | 4 | M39845 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 1.85e-04 | 18 | 89 | 3 | M5290 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 1.85e-04 | 18 | 89 | 3 | MM15577 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 1.85e-04 | 18 | 89 | 3 | MM1385 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 1.85e-04 | 18 | 89 | 3 | M3430 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 2.19e-04 | 19 | 89 | 3 | MM1453 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 2.19e-04 | 19 | 89 | 3 | M47957 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 2.57e-04 | 20 | 89 | 3 | MM1445 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 2.98e-04 | 21 | 89 | 3 | M11650 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 3.43e-04 | 22 | 89 | 3 | MM15104 | |
| Pathway | REACTOME_PROTEIN_METHYLATION | 3.43e-04 | 22 | 89 | 3 | MM15519 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 3.93e-04 | 23 | 89 | 3 | M47512 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 3.93e-04 | 23 | 89 | 3 | MM15222 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 4.47e-04 | 24 | 89 | 3 | M47509 | |
| Pathway | REACTOME_METABOLISM_OF_COFACTORS | 5.06e-04 | 25 | 89 | 3 | MM15574 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 5.06e-04 | 25 | 89 | 3 | M1547 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 5.06e-04 | 25 | 89 | 3 | MM1441 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 5.06e-04 | 25 | 89 | 3 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 5.06e-04 | 25 | 89 | 3 | M47511 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 5.69e-04 | 26 | 89 | 3 | MM1346 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 5.69e-04 | 26 | 89 | 3 | M17941 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 5.69e-04 | 26 | 89 | 3 | MM14495 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 5.69e-04 | 26 | 89 | 3 | MM1371 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 5.69e-04 | 26 | 89 | 3 | MM1431 | |
| Pathway | KEGG_ALZHEIMERS_DISEASE | 6.32e-04 | 166 | 89 | 6 | M16024 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 6.38e-04 | 27 | 89 | 3 | M14899 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 6.38e-04 | 27 | 89 | 3 | M7739 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 6.38e-04 | 27 | 89 | 3 | MM15053 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 7.11e-04 | 28 | 89 | 3 | MM14711 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 7.11e-04 | 28 | 89 | 3 | M47508 | |
| Pathway | KEGG_GLIOMA | 7.49e-04 | 65 | 89 | 4 | M1835 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 7.89e-04 | 29 | 89 | 3 | MM1356 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 7.89e-04 | 29 | 89 | 3 | M13494 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 7.89e-04 | 29 | 89 | 3 | MM1495 | |
| Pathway | WP_ENDOCHONDRAL_OSSIFICATION | 7.94e-04 | 66 | 89 | 4 | MM15875 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 7.97e-04 | 115 | 89 | 5 | M9387 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 8.73e-04 | 30 | 89 | 3 | M9664 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 8.73e-04 | 30 | 89 | 3 | MM15170 | |
| Pathway | WP_MELANOMA | 8.88e-04 | 68 | 89 | 4 | M39811 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 9.10e-04 | 178 | 89 | 6 | M2890 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 1.06e-03 | 32 | 89 | 3 | MM1355 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 1.06e-03 | 32 | 89 | 3 | MM15143 | |
| Pathway | WP_RAS_SIGNALING | 1.08e-03 | 184 | 89 | 6 | M39764 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 1.16e-03 | 33 | 89 | 3 | M9494 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 1.22e-03 | 74 | 89 | 4 | MM15962 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 1.24e-03 | 189 | 89 | 6 | MM14772 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 1.26e-03 | 34 | 89 | 3 | M10287 | |
| Pathway | WP_GLYCOGEN_METABOLISM | 1.26e-03 | 34 | 89 | 3 | MM15985 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 1.26e-03 | 34 | 89 | 3 | MM1399 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 1.35e-03 | 76 | 89 | 4 | M9052 | |
| Pathway | REACTOME_RAF_ACTIVATION | 1.38e-03 | 35 | 89 | 3 | MM15271 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.38e-03 | 35 | 89 | 3 | MM15109 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 1.38e-03 | 35 | 89 | 3 | MM15114 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.89e-03 | 39 | 89 | 3 | MM14496 | |
| Pathway | BIOCARTA_FCER1_PATHWAY | 1.89e-03 | 39 | 89 | 3 | MM1397 | |
| Pathway | BIOCARTA_FCER1_PATHWAY | 1.89e-03 | 39 | 89 | 3 | M1908 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 2.03e-03 | 40 | 89 | 3 | M39595 | |
| Pathway | BIOCARTA_TCR_PATHWAY | 2.34e-03 | 42 | 89 | 3 | MM1504 | |
| Pathway | BIOCARTA_TCR_PATHWAY | 2.67e-03 | 44 | 89 | 3 | M19784 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 2.72e-03 | 92 | 89 | 4 | MM14881 | |
| Pubmed | 8.19e-10 | 5 | 126 | 4 | 18570893 | ||
| Pubmed | Interaction between metabotropic glutamate receptor 7 and alpha tubulin. | 2.04e-08 | 9 | 126 | 4 | 11953448 | |
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 29932249 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 18370588 | ||
| Pubmed | Structural organization of the human CaMIII calmodulin gene. | 4.64e-08 | 3 | 126 | 3 | 2223880 | |
| Pubmed | Molecular mechanisms of calmodulin's functional versatility. | 4.64e-08 | 3 | 126 | 3 | 9923700 | |
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 9681195 | ||
| Pubmed | Allosteric mechanism of water-channel gating by Ca2+-calmodulin. | 4.64e-08 | 3 | 126 | 3 | 23893133 | |
| Pubmed | Expression of HIV-1 envelope glycoprotein alters cellular calmodulin. | 4.64e-08 | 3 | 126 | 3 | 8573130 | |
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 10899953 | ||
| Pubmed | Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin. | 4.64e-08 | 3 | 126 | 3 | 9278050 | |
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 15719022 | ||
| Pubmed | Nef of HIV-1 interacts directly with calcium-bound calmodulin. | 4.64e-08 | 3 | 126 | 3 | 11847276 | |
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 10416864 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 7828884 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 8862395 | ||
| Pubmed | Calmodulin is required for cell-cycle progression during G1 and mitosis. | 4.64e-08 | 3 | 126 | 3 | 2469574 | |
| Pubmed | Myristoyl moiety of HIV Nef is involved in regulation of the interaction with calmodulin in vivo. | 4.64e-08 | 3 | 126 | 3 | 15632291 | |
| Pubmed | Blocking the Ca2+-induced conformational transitions in calmodulin with disulfide bonds. | 4.64e-08 | 3 | 126 | 3 | 8631777 | |
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 18553937 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 14978283 | ||
| Pubmed | Calmodulin and HIV type 1: interactions with Gag and Gag products. | 4.64e-08 | 3 | 126 | 3 | 11054265 | |
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 33191766 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 18940602 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 25268113 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 19651602 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 26969752 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 8314583 | ||
| Pubmed | Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. | 4.64e-08 | 3 | 126 | 3 | 11807546 | |
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 8312049 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 37380439 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 31628181 | ||
| Pubmed | Sequence homology of the 3'-untranslated region of calmodulin III in mammals. | 4.64e-08 | 3 | 126 | 3 | 11710561 | |
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 2445749 | ||
| Pubmed | Signal peptide fragments of preprolactin and HIV-1 p-gp160 interact with calmodulin. | 4.64e-08 | 3 | 126 | 3 | 9362478 | |
| Pubmed | The abundance of calmodulin mRNAs is regulated in phosphorylase kinase-deficient skeletal muscle. | 4.64e-08 | 3 | 126 | 3 | 3384819 | |
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 21799007 | ||
| Pubmed | Binding of calmodulin to the HIV-1 matrix protein triggers myristate exposure. | 4.64e-08 | 3 | 126 | 3 | 20956522 | |
| Pubmed | Noncanonical binding of calmodulin to aquaporin-0: implications for channel regulation. | 4.64e-08 | 3 | 126 | 3 | 18786401 | |
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 11072229 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 16229872 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 15063758 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 8226798 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 9658102 | ||
| Pubmed | The ankyrin repeats of TRPV1 bind multiple ligands and modulate channel sensitivity. | 4.64e-08 | 3 | 126 | 3 | 17582331 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | SYNRG RC3H2 CMTR1 CALM2 WASHC2A SH3PXD2B ATXN2 SYTL4 LMO7 UGDH CD44 UNK LSM14B NNT TOP2B | 6.29e-08 | 724 | 126 | 15 | 36232890 |
| Pubmed | SYNRG RC3H2 ARHGEF12 WASHC2A DENND4C UNK CAMSAP2 WWC1 PPP6R3 | 7.72e-08 | 209 | 126 | 9 | 36779422 | |
| Pubmed | A reassessment of the inhibitory capacity of human FKBP38 on calcineurin. | 7.95e-08 | 12 | 126 | 4 | 15757646 | |
| Pubmed | A calmodulin-binding sequence in the C-terminus of human cardiac titin kinase. | 1.85e-07 | 4 | 126 | 3 | 7607248 | |
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 27516456 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 30842726 | ||
| Pubmed | Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. | 1.85e-07 | 4 | 126 | 3 | 23040497 | |
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 16299511 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 25437912 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 17046994 | ||
| Pubmed | A network of control mediated by regulator of calcium/calmodulin-dependent signaling. | 1.85e-07 | 4 | 126 | 3 | 15499021 | |
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 10692436 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 16478480 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 21167176 | ||
| Pubmed | Calcium/calmodulin regulates ubiquitination of the ubiquitin-specific protease TRE17/USP6. | 1.85e-07 | 4 | 126 | 3 | 16127172 | |
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 20226167 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 10823944 | ||
| Pubmed | Calm1 signaling pathway is essential for the migration of mouse precerebellar neurons. | 1.85e-07 | 4 | 126 | 3 | 25519244 | |
| Pubmed | Endogenous calmodulin interacts with the epidermal growth factor receptor in living cells. | 1.85e-07 | 4 | 126 | 3 | 14960328 | |
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 22405011 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 11736632 | ||
| Pubmed | Activation mechanism of a human SK-calmodulin channel complex elucidated by cryo-EM structures. | 1.85e-07 | 4 | 126 | 3 | 29724949 | |
| Pubmed | A calcium sensor in the sodium channel modulates cardiac excitability. | 1.85e-07 | 4 | 126 | 3 | 11807557 | |
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 11286509 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 20953164 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 19855925 | ||
| Pubmed | Calmodulin binding to the Fas death domain. Regulation by Fas activation. | 1.85e-07 | 4 | 126 | 3 | 14594800 | |
| Pubmed | Structure of calmodulin bound to the hydrophobic IQ domain of the cardiac Ca(v)1.2 calcium channel. | 1.85e-07 | 4 | 126 | 3 | 16338416 | |
| Pubmed | Role of calmodulin in HIV-potentiated Fas-mediated apoptosis. | 1.85e-07 | 4 | 126 | 3 | 8780394 | |
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 19279214 | ||
| Pubmed | Requirement of calmodulin binding by HIV-1 gp160 for enhanced FAS-mediated apoptosis. | 1.85e-07 | 4 | 126 | 3 | 10625668 | |
| Pubmed | Molecular basis of the death-associated protein kinase-calcium/calmodulin regulator complex. | 1.85e-07 | 4 | 126 | 3 | 20103772 | |
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 9096366 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 12577052 | ||
| Pubmed | FRET detection of calmodulin binding to the cardiac RyR2 calcium release channel. | 1.85e-07 | 4 | 126 | 3 | 22067155 | |
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 25441029 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 11278607 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 16505387 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 26164367 | ||
| Pubmed | CYLC1 NOC2L SMCHD1 LYST PDIA3 FER1L6 SLC3A2 RPS6KC1 BPTF ZBED4 SACS LMO7 STARD9 VPS13A FAM169A OGDHL JAKMIP1 CAMSAP2 STAG2 TOP2B | 2.54e-07 | 1442 | 126 | 20 | 35575683 | |
| Pubmed | CALM2 CALM3 SCYL3 RALGAPB COPG2 SPAG9 SRFBP1 PDIA3 SLC3A2 BLMH TIAM1 ATXN2 PTPRZ1 VPS13A CD44 PPP6R3 FTSJ3 | 2.63e-07 | 1049 | 126 | 17 | 27880917 | |
| Pubmed | 4.62e-07 | 5 | 126 | 3 | 27165696 | ||
| Pubmed | 4.62e-07 | 5 | 126 | 3 | 11981030 | ||
| Pubmed | Rab3B in human platelet is membrane bound and interacts with Ca(2+)/calmodulin. | 4.62e-07 | 5 | 126 | 3 | 11741295 | |
| Pubmed | Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors. | 4.62e-07 | 5 | 126 | 3 | 19632986 | |
| Pubmed | 4.62e-07 | 5 | 126 | 3 | 3111527 | ||
| Pubmed | 4.62e-07 | 5 | 126 | 3 | 17719545 | ||
| Pubmed | 4.62e-07 | 5 | 126 | 3 | 35568036 | ||
| Pubmed | 4.62e-07 | 5 | 126 | 3 | 25232683 | ||
| Pubmed | Current inhibition of human EAG1 potassium channels by the Ca2+ binding protein S100B. | 4.62e-07 | 5 | 126 | 3 | 20708613 | |
| Pubmed | Pathogenic NPHP5 mutations impair protein interaction with Cep290, a prerequisite for ciliogenesis. | 4.62e-07 | 5 | 126 | 3 | 23446637 | |
| Pubmed | 4.62e-07 | 5 | 126 | 3 | 15140941 | ||
| Pubmed | 4.62e-07 | 5 | 126 | 3 | 12034722 | ||
| Pubmed | 4.62e-07 | 5 | 126 | 3 | 32522888 | ||
| Pubmed | Inhibition of human ether à go-go potassium channels by Ca(2+)/calmodulin. | 4.62e-07 | 5 | 126 | 3 | 10880439 | |
| Interaction | C11orf65 interactions | 9.97e-07 | 13 | 126 | 4 | int:C11orf65 | |
| Interaction | SPATA17 interactions | 8.20e-06 | 7 | 126 | 3 | int:SPATA17 | |
| Interaction | KCNN1 interactions | 1.31e-05 | 8 | 126 | 3 | int:KCNN1 | |
| Interaction | ARPP21 interactions | 1.31e-05 | 8 | 126 | 3 | int:ARPP21 | |
| Interaction | GPHA2 interactions | 1.66e-05 | 25 | 126 | 4 | int:GPHA2 | |
| Interaction | PHKG2 interactions | 2.29e-05 | 91 | 126 | 6 | int:PHKG2 | |
| Interaction | IQCG interactions | 2.77e-05 | 10 | 126 | 3 | int:IQCG | |
| Interaction | PPEF2 interactions | 3.07e-05 | 29 | 126 | 4 | int:PPEF2 | |
| Interaction | ESCO1 interactions | 3.52e-05 | 30 | 126 | 4 | int:ESCO1 | |
| Interaction | CCDC102A interactions | 4.29e-05 | 62 | 126 | 5 | int:CCDC102A | |
| Interaction | CALM2 interactions | 4.66e-05 | 206 | 126 | 8 | int:CALM2 | |
| Interaction | UNK interactions | RC3H2 CALM1 CALM2 CALM3 YIPF4 HMGCR PDIA3 ATXN2 UNK TOP2B PPP6R3 | 5.18e-05 | 408 | 126 | 11 | int:UNK |
| Interaction | CALM3 interactions | RC3H2 FLT1 EPHA6 CALM2 CALM3 ARHGEF12 DENND4C LMO7 VPS13A UNK | 6.01e-05 | 343 | 126 | 10 | int:CALM3 |
| Interaction | HDAC4 interactions | THSD7A CALM1 SMCHD1 PDIA3 DENND4C RPS6KC1 TIAM1 ATXN2 LMO7 FMN1 UGDH UNK TLN2 CAMSAP2 TOP2B | 6.42e-05 | 744 | 126 | 15 | int:HDAC4 |
| Interaction | IQCN interactions | 7.71e-05 | 70 | 126 | 5 | int:IQCN | |
| Interaction | C3orf18 interactions | 8.55e-05 | 115 | 126 | 6 | int:C3orf18 | |
| Interaction | KIF1C interactions | 1.08e-04 | 120 | 126 | 6 | int:KIF1C | |
| Interaction | ZNF280A interactions | 1.26e-04 | 16 | 126 | 3 | int:ZNF280A | |
| Interaction | NUDT9 interactions | 1.36e-04 | 42 | 126 | 4 | int:NUDT9 | |
| Interaction | CALM1 interactions | CALM1 CALM2 CALML3 ARHGEF12 LYST PDIA3 DENND4C BLMH ZBED4 LMO7 MCM3AP VPS13A UNK | 1.52e-04 | 626 | 126 | 13 | int:CALM1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr18q22 | 3.63e-05 | 67 | 126 | 4 | chr18q22 | |
| Cytoband | 18q22.2 | 1.56e-04 | 7 | 126 | 2 | 18q22.2 | |
| GeneFamily | EF-hand domain containing | 4.81e-05 | 219 | 79 | 7 | 863 | |
| GeneFamily | Aldehyde dehydrogenases | 7.40e-05 | 19 | 79 | 3 | 398 | |
| GeneFamily | StAR related lipid transfer domain containing | 1.91e-03 | 15 | 79 | 2 | 759 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.91e-03 | 15 | 79 | 2 | 529 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 2.82e-03 | 134 | 79 | 4 | 861 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.01e-03 | 66 | 79 | 3 | 722 | |
| GeneFamily | PDZ domain containing | 4.43e-03 | 152 | 79 | 4 | 1220 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MAN2A1 SMCHD1 BPTF DLC1 TIAM1 ATXN2 VPS13A FAM169A PARN CAMSAP2 WWC1 SEC14L1 | 2.70e-06 | 466 | 126 | 12 | M13522 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MAN2A1 SMCHD1 SPAG9 SOCS6 BPTF DLC1 TIAM1 SACS ATXN2 VPS13A FAM169A PARN CAMSAP2 STAG2 WWC1 SEC14L1 | 3.64e-06 | 856 | 126 | 16 | M4500 |
| Coexpression | JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP | 1.65e-05 | 382 | 126 | 10 | M38972 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | MAN2A1 LYST BLMH BPTF ATXN2 PTPRZ1 SNX7 MCM3AP UGDH CD44 TOP2B | 2.16e-05 | 481 | 126 | 11 | M3898 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | CHL1 SLITRK4 NLGN1 ADAMTS5 ZFHX4 LGI2 KCND2 SPOCK3 FAM169A OGDHL TLN2 JAKMIP1 CAMSAP2 | 3.53e-05 | 703 | 126 | 13 | M39070 |
| Coexpression | GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN | 3.84e-05 | 190 | 126 | 7 | M8457 | |
| Coexpression | GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN | 4.99e-05 | 198 | 126 | 7 | M7610 | |
| Coexpression | GSE29949_MICROGLIA_VS_DC_BRAIN_UP | 5.15e-05 | 199 | 126 | 7 | M8399 | |
| Coexpression | GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_UP | 5.32e-05 | 200 | 126 | 7 | M6604 | |
| Coexpression | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP | 7.02e-05 | 17 | 126 | 3 | MM686 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CHL1 THSD7A SLITRK4 ARHGEF12 NLGN1 LYST FSIP2 ZFHX4 LGI2 NETO1 SPOCK3 FAM169A OGDHL PAPPA TLN2 CAMSAP2 | 8.28e-05 | 1106 | 126 | 16 | M39071 |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.12e-07 | 181 | 125 | 7 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 1.05e-06 | 188 | 125 | 7 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-06 | 189 | 125 | 7 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-06 | 189 | 125 | 7 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-06 | 191 | 125 | 7 | 9c0ee270209b02043393416ecc9a81ddedfbb8b6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-06 | 193 | 125 | 7 | 2c15186d15545804cc262da9137ab825609d4b2c | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 1.25e-06 | 193 | 125 | 7 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-06 | 193 | 125 | 7 | 8b77625bf3c87d39767fb391d1beaca4ab02342b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-06 | 193 | 125 | 7 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Interneuron|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.58e-06 | 200 | 125 | 7 | a313b9a8bde1ea80a6eae183b76fba46b86558b4 | |
| ToppCell | 18-Airway-Epithelial-Goblet-like_secretory|Airway / Age, Tissue, Lineage and Cell class | 4.71e-06 | 153 | 125 | 6 | 14a60220e169ce642771636de982a7b02e5b2608 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.91e-06 | 171 | 125 | 6 | 25c1979e972c959e1ce4c57804f976f53a247ad7 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.91e-06 | 171 | 125 | 6 | fe27bf581c75ef33c2848878e51ed16b275a4c8e | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 176 | 125 | 6 | 27e5115fae5f0f63b333bc99fbf6a6d4c9182c46 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 178 | 125 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | IPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class | 1.19e-05 | 180 | 125 | 6 | 1fa54bf4dba72866b2295639d991af639341bc08 | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 1.23e-05 | 181 | 125 | 6 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 182 | 125 | 6 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 1.39e-05 | 185 | 125 | 6 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.48e-05 | 187 | 125 | 6 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.62e-05 | 190 | 125 | 6 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 190 | 125 | 6 | e792e42fc49472eaf974eb0905819eb51a1da8e5 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.72e-05 | 192 | 125 | 6 | 30cefa0990ba1f379f350bfbf994a78db145075e | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 192 | 125 | 6 | 550a6574a93acadb43c449094565c73ca51a0c5c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.72e-05 | 192 | 125 | 6 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-05 | 193 | 125 | 6 | b03d908d4b8940927f72c76a1b0f237d13f39056 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.77e-05 | 193 | 125 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-05 | 193 | 125 | 6 | 40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.77e-05 | 193 | 125 | 6 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | IPF-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 1.82e-05 | 194 | 125 | 6 | da3e1d39575969a069ef43e552afe94b2f441d0b | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.82e-05 | 194 | 125 | 6 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | IPF-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | 1.88e-05 | 195 | 125 | 6 | 50edda117b438b9c3616191884007466f6d974f0 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-05 | 195 | 125 | 6 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 1.99e-05 | 197 | 125 | 6 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 1.99e-05 | 197 | 125 | 6 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | Control-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 1.99e-05 | 197 | 125 | 6 | 64cc5f61c88e9560b0f8f6f3151255dffb5c3d66 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-05 | 198 | 125 | 6 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.04e-05 | 198 | 125 | 6 | 6a539d3b47bd2d4a7ad5c67cad23facffc0ac45f | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-Neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.04e-05 | 198 | 125 | 6 | 90ebefc9ba8dc2a81471e5693384f5ce56f06298 | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-05 | 198 | 125 | 6 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.10e-05 | 199 | 125 | 6 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-NK_CD56bright|IIF / Disease, condition lineage and cell class | 2.10e-05 | 199 | 125 | 6 | 9eb2b7d4900b118338590db778a47504559e228d | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-05 | 200 | 125 | 6 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.16e-05 | 200 | 125 | 6 | 16a7c398626b6e82b394eb3ef013bda3a788659d | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | 1276bfa911fddada4235e12e3081baa53164574b | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.16e-05 | 200 | 125 | 6 | 780d47f8eff630020dfae32218de495a7e9dbad6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.16e-05 | 200 | 125 | 6 | 28dd127787a57276253548d1f030814b1af64481 | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 2.16e-05 | 200 | 125 | 6 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | 5ec469267747dce3601c1d8ad01af89fa5b29acc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | c65e6336725856c4b5f6aeba1cf86a23ec815d34 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | 501a3b93624df463458a35d3e6648d4ccc941724 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | d1f36a8232411933b1494168ec912fd0e5246428 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | e79d93d55b25804f2608185168da472301b6ebca | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-GGH-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | 48303e499251d6754cfa991dc2d96c5563b2123c | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-05 | 200 | 125 | 6 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | 117a25b3b9cdbc2e198381350a8362bee25e82e7 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-GGH|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | 4802dd6cae84b41746227a5d1aa1c9b858495e36 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | d459e51507bf26865e6e7e04411379ec82a3edf8 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | 320d5a3a1e7da2fa8f1a164e29e180ec8ac9889c | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Vipr2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.17e-05 | 119 | 125 | 5 | 6425425b2e622c97b6c74c530ccbfe394d3b202d | |
| ToppCell | COVID-19_Severe-MAIT|COVID-19_Severe / disease group, cell group and cell class | 6.55e-05 | 150 | 125 | 5 | 923ea7ecc0aa05fb0396082cd9c3d1594135f1e0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.76e-05 | 151 | 125 | 5 | 16fc903fc71e25717b9908416f0bcd29c0a65a61 | |
| ToppCell | COVID-19-Heart-Adipocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.19e-05 | 153 | 125 | 5 | 93958bd9c951222ba5b740d1cb83fd5d78a10e1e | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.65e-05 | 155 | 125 | 5 | e1a20e88b9c0eaf7ca7004acc0eda096d1588563 | |
| ToppCell | (1)_Control_(PBS)-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 8.88e-05 | 160 | 125 | 5 | ab769516f9f7798d1390ef215caf22a2d3d53e63 | |
| ToppCell | IIF-Lymphocyte-T_NK-NK_CD56bright|IIF / Disease, Lineage and Cell Type | 9.15e-05 | 161 | 125 | 5 | b1bd1074ecba4cf171d748e2f686e9a99c0f0e89 | |
| ToppCell | COVID-CD8-memory_CD4|COVID / Condition, Cell_class and T cell subcluster | 9.42e-05 | 162 | 125 | 5 | 22b2a32217d357146c117e618813d451510a1801 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.98e-05 | 164 | 125 | 5 | d847d509bb1791638032ade6755d8164586b5bd5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 165 | 125 | 5 | dc570154baed59ed109e5369589448e075ba66a9 | |
| ToppCell | Control-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 1.06e-04 | 166 | 125 | 5 | 32ebaefa6c074b28193fff764ee7c2c0e9357e20 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-D_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-04 | 166 | 125 | 5 | 2e4cb4056e6b0c43290a5588ff525f5f05b8beee | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.06e-04 | 166 | 125 | 5 | de319c960b0cd90b294f677d1ea1b013a2ce2d53 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-D_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-04 | 166 | 125 | 5 | eb8d972326a734549675307e411fc795af66da70 | |
| ToppCell | Control-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class | 1.06e-04 | 166 | 125 | 5 | 1ed3788257e14f097862b999f020bfe2a57de52b | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Trm/em_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.15e-04 | 169 | 125 | 5 | 17568e7aacfdcd96c469bae57d5ffad04954e9bd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 170 | 125 | 5 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 170 | 125 | 5 | 45de83a2231208b8e1f21061d0b91644b4a3ba93 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.18e-04 | 170 | 125 | 5 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 170 | 125 | 5 | 833b4f44ea1fa673dfc6b43ce45a79fe68ae3b05 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-04 | 172 | 125 | 5 | a9e13aa36087170dadca421ba9de588e5a1cf715 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 172 | 125 | 5 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 172 | 125 | 5 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.32e-04 | 174 | 125 | 5 | edf839d79ac58921f4e788f3b2cb2ae0d6af4b9e | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.32e-04 | 174 | 125 | 5 | 65539f69100db0b7d90b1b39ee15ab8281f86461 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-04 | 175 | 125 | 5 | 96219e58dcb327fd27190be78193e7a0d611e62b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 175 | 125 | 5 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-04 | 175 | 125 | 5 | cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Immature_Interneurons|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.39e-04 | 176 | 125 | 5 | 62870115e31170c8b42eec57c709e0fe32388b37 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-04 | 176 | 125 | 5 | bfa1633e1b7a8a2f04d37fa07284fe9bc0199f46 | |
| ToppCell | normal_Lung-Fibroblasts-Mesothelial_cells|normal_Lung / Location, Cell class and cell subclass | 1.39e-04 | 176 | 125 | 5 | f31d7234053085a82cf9d55aeedd1e04d34789c3 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-04 | 176 | 125 | 5 | 90f8bb11f339f67f08692a0c33dd420f5cda2861 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 1.39e-04 | 176 | 125 | 5 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 177 | 125 | 5 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_SSTR1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-04 | 177 | 125 | 5 | fdab7b7ddfb06f913b8224c0c80574dc3cf4cbd4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-04 | 178 | 125 | 5 | 375156ba1c7b8592bf733c75f24968161f7cfa09 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 179 | 125 | 5 | a09647750eba9d93c5efc1db3b555fefb5eec7b5 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.50e-04 | 179 | 125 | 5 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-04 | 179 | 125 | 5 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 1.50e-04 | 179 | 125 | 5 | 431e1b29015ec817f778499106d24b19cfc825ae | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 1.50e-04 | 179 | 125 | 5 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| Drug | Nsc642900 | 8.94e-10 | 4 | 126 | 4 | CID000498959 | |
| Drug | 85318-25-8 | 8.94e-10 | 4 | 126 | 4 | CID006439702 | |
| Drug | chloraniformethan | 8.94e-10 | 4 | 126 | 4 | CID000030331 | |
| Drug | Ti 233 | 8.94e-10 | 4 | 126 | 4 | CID000173248 | |
| Drug | diisopropylphosphoramidite | 8.94e-10 | 4 | 126 | 4 | CID000080867 | |
| Drug | herbarumin III | 8.94e-10 | 4 | 126 | 4 | CID000643678 | |
| Drug | thiomethylpromazine | 8.94e-10 | 4 | 126 | 4 | CID000070583 | |
| Drug | KS-504e | 8.94e-10 | 4 | 126 | 4 | CID000129559 | |
| Drug | KS-504d | 8.94e-10 | 4 | 126 | 4 | CID000129557 | |
| Drug | Archanagelicine | 8.94e-10 | 4 | 126 | 4 | CID003083773 | |
| Drug | N,N-dimethyladriamycin-14-valerate | 8.94e-10 | 4 | 126 | 4 | CID000127194 | |
| Drug | KS-502 | 8.94e-10 | 4 | 126 | 4 | CID000129242 | |
| Drug | KS-501 | 8.94e-10 | 4 | 126 | 4 | CID000129240 | |
| Drug | 2'-methoxykobusin | 8.94e-10 | 4 | 126 | 4 | CID000637889 | |
| Drug | PS-990 | 8.94e-10 | 4 | 126 | 4 | CID000157810 | |
| Drug | D 890 | 4.45e-09 | 5 | 126 | 4 | CID000134083 | |
| Drug | NSC-36360 | 4.45e-09 | 5 | 126 | 4 | CID000133340 | |
| Drug | alpha-CAO | 4.45e-09 | 5 | 126 | 4 | CID000196600 | |
| Drug | 4H-1,4-benzothiazin-3-one | 4.45e-09 | 5 | 126 | 4 | CID000021396 | |
| Drug | C16AA | 4.45e-09 | 5 | 126 | 4 | CID000488017 | |
| Drug | auranthine | 4.45e-09 | 5 | 126 | 4 | CID000130919 | |
| Drug | Nor2 chlorpromazine | 4.45e-09 | 5 | 126 | 4 | CID000074981 | |
| Drug | Fsh-beta-(1-15) | 4.45e-09 | 5 | 126 | 4 | CID005748474 | |
| Drug | Ac-dvda | 4.45e-09 | 5 | 126 | 4 | CID000146768 | |
| Drug | VUF 4576 | 4.45e-09 | 5 | 126 | 4 | CID000132784 | |
| Drug | N-(8-aminooctyl)-5-iodonaphthalene-1-sulfonamide | 1.33e-08 | 6 | 126 | 4 | CID000004307 | |
| Drug | benziodarone | 1.33e-08 | 6 | 126 | 4 | CID000006237 | |
| Drug | CI-922 | 1.33e-08 | 6 | 126 | 4 | CID000146938 | |
| Drug | caged PE | 1.33e-08 | 6 | 126 | 4 | CID000192405 | |
| Drug | propyl-methylenedioxyindene | 1.33e-08 | 6 | 126 | 4 | CID000145934 | |
| Drug | 1-(4-pyridyl)ethanol | 3.09e-08 | 7 | 126 | 4 | CID000090919 | |
| Drug | trifluoperazine sulfoxide | 3.09e-08 | 7 | 126 | 4 | CID000159622 | |
| Drug | T 7188 | 3.09e-08 | 7 | 126 | 4 | CID000003311 | |
| Drug | AC1L3PE4 | 3.09e-08 | 7 | 126 | 4 | CID000093048 | |
| Drug | O-4-(ethoxybutyl)berbamine | 3.09e-08 | 7 | 126 | 4 | CID000188375 | |
| Drug | KHL-8430 | 3.09e-08 | 7 | 126 | 4 | CID000195711 | |
| Drug | CPU57 | 3.09e-08 | 7 | 126 | 4 | CID000195730 | |
| Drug | proxyl nitroxide | 6.15e-08 | 8 | 126 | 4 | CID000076702 | |
| Drug | niludipine | 6.15e-08 | 8 | 126 | 4 | CID000089767 | |
| Drug | Ro 22-4839 | 6.15e-08 | 8 | 126 | 4 | CID000065839 | |
| Drug | HT-74 | 6.15e-08 | 8 | 126 | 4 | CID000126681 | |
| Drug | 3,7,8-trihydroxy-CPZ | 6.15e-08 | 8 | 126 | 4 | CID000467415 | |
| Drug | KS-504a | 6.15e-08 | 8 | 126 | 4 | CID000129577 | |
| Drug | 7,8-diOH-CPZ | 1.10e-07 | 9 | 126 | 4 | CID000159916 | |
| Drug | KS-505a | 1.10e-07 | 9 | 126 | 4 | CID003081782 | |
| Drug | Oxybutynin chloride [1508-65-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.31e-07 | 194 | 126 | 10 | 3168_DN | |
| Drug | NSC366363 | 1.65e-07 | 3 | 126 | 3 | CID000339501 | |
| Drug | AC1NDS53 | 1.65e-07 | 3 | 126 | 3 | CID004630710 | |
| Drug | tatsiensine | 1.65e-07 | 3 | 126 | 3 | CID000163526 | |
| Drug | delcosine | 1.65e-07 | 3 | 126 | 3 | CID000120726 | |
| Drug | 1-isoamyl-3-isobutylxanthine | 1.83e-07 | 10 | 126 | 4 | CID000152034 | |
| Drug | norchlorpromazine | 1.83e-07 | 10 | 126 | 4 | CID000062875 | |
| Drug | indolidan | 2.86e-07 | 11 | 126 | 4 | CID005284402 | |
| Drug | 4-iodotamoxifen | 2.86e-07 | 11 | 126 | 4 | CID003037006 | |
| Drug | alpha-amyrin linoleate | 2.86e-07 | 11 | 126 | 4 | CID005318324 | |
| Drug | IQ-3 | 2.86e-07 | 11 | 126 | 4 | CID000028212 | |
| Drug | AC1L2NX7 | 2.86e-07 | 11 | 126 | 4 | CID000125056 | |
| Drug | Ins(1,3)P2 | 2.86e-07 | 11 | 126 | 4 | CID000128419 | |
| Drug | 1-(5-aminopentyl)-3-phenylthiourea | 2.86e-07 | 11 | 126 | 4 | CID003035524 | |
| Drug | CV-159 | 4.28e-07 | 12 | 126 | 4 | CID000135211 | |
| Drug | tiflucarbine | 4.28e-07 | 12 | 126 | 4 | CID000065677 | |
| Drug | Ant-dATP | 4.28e-07 | 12 | 126 | 4 | CID000131323 | |
| Drug | daurisoline | 6.15e-07 | 13 | 126 | 4 | CID000051106 | |
| Drug | NSC708927 | 6.15e-07 | 13 | 126 | 4 | CID011970115 | |
| Drug | APP 201-533 | 6.15e-07 | 13 | 126 | 4 | CID000133461 | |
| Drug | SC-52458 | 6.15e-07 | 13 | 126 | 4 | CID000132706 | |
| Drug | CTK0F9956 | 6.59e-07 | 4 | 126 | 3 | CID011779542 | |
| Drug | cloxacepride | 6.59e-07 | 4 | 126 | 3 | CID000068859 | |
| Drug | Roylin | 6.59e-07 | 4 | 126 | 3 | CID000099924 | |
| Drug | AC1L3X1Y | 7.26e-07 | 31 | 126 | 5 | CID000123655 | |
| Drug | acepromazine | 7.26e-07 | 31 | 126 | 5 | CID000006077 | |
| Drug | HCOH (hydroxymethylene) | 7.26e-07 | 31 | 126 | 5 | CID006432217 | |
| Drug | 9-anthroylcholine | 1.16e-06 | 15 | 126 | 4 | CID000173246 | |
| Drug | AC1OCACR | 1.17e-06 | 34 | 126 | 5 | CID006914630 | |
| Drug | desethylamiodarone | 1.17e-06 | 34 | 126 | 5 | CID000104774 | |
| Drug | fluphenazine-N-mustard | 1.55e-06 | 16 | 126 | 4 | CID000134141 | |
| Drug | NSC-114340 | 1.55e-06 | 16 | 126 | 4 | CID000004598 | |
| Drug | fendiline | 1.55e-06 | 16 | 126 | 4 | CID000003336 | |
| Drug | Org 30029 | 1.55e-06 | 16 | 126 | 4 | CID006336059 | |
| Drug | jujubogenin | 1.64e-06 | 5 | 126 | 3 | CID005318721 | |
| Drug | AC1NS8P3 | 1.64e-06 | 5 | 126 | 3 | CID005356151 | |
| Drug | Y-acid | 1.64e-06 | 5 | 126 | 3 | CID000007022 | |
| Drug | Ant-ATP | 1.64e-06 | 5 | 126 | 3 | CID000134953 | |
| Drug | MIANS | 1.81e-06 | 37 | 126 | 5 | CID000119532 | |
| Drug | Mastoparan X | 2.01e-06 | 17 | 126 | 4 | CID005488554 | |
| Drug | desmethoxyverapamil | 2.01e-06 | 17 | 126 | 4 | CID000065832 | |
| Drug | Org 9935 | 2.01e-06 | 17 | 126 | 4 | CID000131100 | |
| Drug | ICI D7114 | 2.01e-06 | 17 | 126 | 4 | CID000121877 | |
| Drug | chlorpromazine sulfoxide | 2.58e-06 | 18 | 126 | 4 | CID000070413 | |
| Drug | 8-azido cyclic AMP | 2.58e-06 | 18 | 126 | 4 | CID000115296 | |
| Drug | AC1L19BP | 2.58e-06 | 18 | 126 | 4 | CID000000477 | |
| Drug | MABI | 3.25e-06 | 19 | 126 | 4 | CID000188268 | |
| Drug | AC1NSV6X | 3.27e-06 | 6 | 126 | 3 | CID005317173 | |
| Drug | 2,5-diketocamphane | 3.27e-06 | 6 | 126 | 3 | CID000020218 | |
| Drug | AC1LCMSV | 3.27e-06 | 6 | 126 | 3 | CID000633347 | |
| Drug | magnesium acetate | 4.04e-06 | 20 | 126 | 4 | CID000008896 | |
| Drug | 4pal | 4.04e-06 | 20 | 126 | 4 | CID005748175 | |
| Drug | DEPMPO | 4.04e-06 | 20 | 126 | 4 | CID000119606 | |
| Drug | niguldipine | 4.90e-06 | 45 | 126 | 5 | CID000001236 | |
| Drug | decanoylcarnitine | 4.98e-06 | 21 | 126 | 4 | CID000150921 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 8.30e-06 | 10 | 123 | 3 | C1631597 | |
| Disease | Colorectal Carcinoma | CHL1 ALDH1L1 DLC1 TIAM1 SH3TC1 SACS LMO7 MCM3AP PANK4 VPS13A JAKMIP1 CAMSAP2 | 3.88e-05 | 702 | 123 | 12 | C0009402 |
| Disease | cancer (implicated_via_orthology) | 1.37e-04 | 268 | 123 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | Phencyclidine-Related Disorders | 3.57e-04 | 7 | 123 | 2 | C0236742 | |
| Disease | Phencyclidine Abuse | 3.57e-04 | 7 | 123 | 2 | C0031391 | |
| Disease | ovarian carcinoma | 4.09e-04 | 321 | 123 | 7 | EFO_0001075 | |
| Disease | osteoarthritis (is_marker_for) | 4.20e-04 | 35 | 123 | 3 | DOID:8398 (is_marker_for) | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 4.69e-04 | 86 | 123 | 4 | EFO_0008595, EFO_0020945 | |
| Disease | Cannabis Abuse | 7.59e-04 | 10 | 123 | 2 | C0006868 | |
| Disease | Cannabis-Related Disorder | 7.59e-04 | 10 | 123 | 2 | C0236735 | |
| Disease | Hashish Abuse | 7.59e-04 | 10 | 123 | 2 | C0018614 | |
| Disease | eosinophil measurement | 1.10e-03 | 108 | 123 | 4 | EFO_0803540 | |
| Disease | cortisol measurement, response to corticosteroid, response to synacthen | 1.30e-03 | 13 | 123 | 2 | EFO_0005843, EFO_0009175, GO_0031960 | |
| Disease | conotruncal heart malformations | 1.35e-03 | 114 | 123 | 4 | MONDO_0016581 | |
| Disease | Romano-Ward Syndrome | 1.99e-03 | 16 | 123 | 2 | C0035828 | |
| Disease | Cannabis Dependence | 2.25e-03 | 17 | 123 | 2 | C0006870 | |
| Disease | Myeloid Leukemia | 2.52e-03 | 18 | 123 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 2.52e-03 | 18 | 123 | 2 | C0023466 | |
| Disease | Vertigo | 2.78e-03 | 139 | 123 | 4 | HP_0002321 | |
| Disease | pulmonary non-tuberculous mycobacterial infection | 2.81e-03 | 19 | 123 | 2 | MONDO_0018469 | |
| Disease | acetate measurement | 3.12e-03 | 20 | 123 | 2 | EFO_0010112 | |
| Disease | polymyositis | 3.12e-03 | 20 | 123 | 2 | EFO_0003063 | |
| Disease | anorexia nervosa | 3.16e-03 | 70 | 123 | 3 | MONDO_0005351 | |
| Disease | opioid dependence | 3.21e-03 | 237 | 123 | 5 | EFO_0005611 | |
| Disease | hemorrhoid | 3.39e-03 | 147 | 123 | 4 | EFO_0009552 | |
| Disease | glaucoma | 4.01e-03 | 154 | 123 | 4 | MONDO_0005041 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DKEISEAFTSTGFDR | 71 | Q9BXK5 | |
| SDTDAGDAFASAAAV | 81 | O95936 | |
| QSEENGSFLSKDFDA | 136 | Q6NSW5 | |
| AAFAFIVVKDSAGDS | 591 | Q9NUB1 | |
| AEFKEAFSLFDKDGD | 11 | P0DP25 | |
| DDSKFCEETFGSTED | 421 | Q9UNA0 | |
| IIEDSTDFFKSGASS | 361 | Q3SY69 | |
| GFFTIADGESEASFD | 4701 | Q8WXG9 | |
| AEDFGTFFSAVIDAK | 381 | P30038 | |
| STFDIASDAFATFKD | 176 | Q9Y376 | |
| DKEEEHQSGFFSALT | 261 | Q5T2E6 | |
| DKDGDGKISFEEFSA | 141 | Q96LZ3 | |
| SCGVDFEVKAFATDS | 146 | P10523 | |
| KDVDATCSDFNFGTA | 176 | Q8N3C7 | |
| GNDFFIDDSKLASAD | 1336 | Q12830 | |
| AEFKEAFSLFDKDGD | 11 | P0DP24 | |
| EFFDGCKAISADSID | 146 | Q8IWE4 | |
| RKFDSVAFGESQSED | 741 | Q9NZN5 | |
| RADFSESVSGTKFEE | 816 | Q9HBD1 | |
| LNFDFIGSSADESAD | 226 | Q9H2T7 | |
| TGATADFADVADDFE | 401 | Q8TDF5 | |
| TDLGFGSFETAFKDT | 246 | Q68DA7 | |
| EADFFAIDGEFSGIS | 21 | O95453 | |
| GDKSKAFDFLSEETE | 601 | O60271 | |
| DETLTDGKTYDAFVS | 366 | Q13478 | |
| NTFGSAEAATSDDYK | 121 | Q8WWA0 | |
| FGTLSDFFDALDKAD | 461 | Q16706 | |
| QSVKDETFGEYSDSD | 1126 | O00533 | |
| AAAFDSDESEAVGAT | 646 | Q8IX03 | |
| ISFKDAAFDDVSGTD | 671 | Q96S38 | |
| TSEGFAVIKEAFDST | 611 | P04035 | |
| TIKFEGDFDFESANA | 246 | Q9BX40 | |
| DAFTDSAISAKVNGE | 351 | Q99700 | |
| SADGAEFEFDAATVS | 2196 | Q2LD37 | |
| KAHQFEGDSFDSASE | 566 | O60318 | |
| SQVSKTGFVFCSDED | 3181 | Q5CZC0 | |
| SSISDGDGEDSFIFE | 31 | Q9P2G9 | |
| DSFFREASEEAFSGS | 71 | Q9ULD0 | |
| DAEFDESSKTGFKTS | 521 | P35663 | |
| DDFSASEQSKAFGTL | 256 | Q8IXT1 | |
| GSYDASADLFDDIAK | 671 | Q8IXT1 | |
| EDEQAFVSKSGSSFE | 461 | Q9NZV8 | |
| REGFESDTDSEFTFK | 271 | Q8WWI1 | |
| EESDFEAAFSVGATG | 281 | Q7L5L3 | |
| FFGFDEESVDSETLS | 441 | Q96N16 | |
| ETFKAFGGAFSQDED | 476 | Q5JSP0 | |
| DSDDGISASDFDFAV | 441 | Q8N2Q7 | |
| TDFSFADTNEKDADG | 1566 | P23471 | |
| FFAKSSEEELAGVAT | 516 | Q13219 | |
| VDEFLASGFDSESES | 16 | Q9Y3T9 | |
| FGKSATADQEFSKED | 276 | Q9NVE7 | |
| QFSSKFAAAEITEGE | 711 | Q8IZE3 | |
| LAFFGEDSKATTSEA | 1161 | A4D2P6 | |
| EDSKATTSEAFFGIF | 1166 | A4D2P6 | |
| VGDKAVEFFFASDAS | 251 | O94808 | |
| SFSGSGIDDDEDFIS | 291 | P16070 | |
| CFEDSNGKASDFSLE | 191 | Q9H410 | |
| NGKASDFSLEASVAE | 196 | Q9H410 | |
| SDFEKTGFSEEVLDD | 81 | Q5TEA3 | |
| ECSFVSDKDTGLAFF | 631 | Q5VZ89 | |
| DEAEAAAAAKFTGLS | 151 | P08195 | |
| VGDTFEKEETFALSS | 776 | Q9UBF2 | |
| FTAVSEKDDQDGAFT | 376 | Q13867 | |
| DSLKDAFASTSEGHD | 306 | Q9Y6X4 | |
| DDGVDLKSETEGFSA | 1236 | Q99698 | |
| ASEFFVDGLDSDEST | 121 | Q9BV29 | |
| KDSAAFFSTKFDDAD | 116 | A6NNB3 | |
| DAINFDDSGVFDTFK | 341 | O60381 | |
| TEFKEAFSLFDKDGD | 11 | P27482 | |
| AEFKEAFSLFDKDGD | 11 | P0DP23 | |
| DKNTADAITAEGFTD | 246 | Q9BX70 | |
| QSEENGSFLSKDFDA | 136 | Q8TCE6 | |
| KYDADSSGFISAAEL | 116 | O76038 | |
| FVGSDTVNEFKSEDG | 36 | Q92503 | |
| FGAIEKTASATFESA | 216 | Q8N1S5 | |
| LSSRDDEAKGATSDF | 426 | Q9NZJ4 | |
| ESEDGVSASAFDFTV | 396 | Q8NFZ4 | |
| HGVSFDISFDKEDSV | 436 | Q08AD1 | |
| SFDDAFKADSLVEGT | 66 | Q8N1G2 | |
| FSEISVGAEFNKDDC | 391 | P02748 | |
| YSQKFEFETGDETSD | 526 | Q9UF33 | |
| VESGAGEASKFSDDH | 91 | Q13423 | |
| FSGKTIFTEEDTDET | 1506 | Q2WGJ9 | |
| GKSALEAESESLDSF | 191 | Q96C24 | |
| GNSIKDVDVSDFTDF | 386 | Q8IW52 | |
| EKDSETSYAVDGLFS | 91 | Q765I0 | |
| TAADSFEFKAHVEGD | 406 | A6NHR9 | |
| DSSEDDKEYVGFATL | 116 | O43236 | |
| DTAAVKVEFDEEFSG | 1266 | Q02880 | |
| VSDGSADDFSKVVDE | 1371 | Q9UPZ6 | |
| KSGSLDDSFSDFQEL | 466 | Q9UMZ2 | |
| TDDGFTDFKTADSVS | 566 | Q9UMZ2 | |
| DETFFVIADSSKAGL | 336 | Q8N0V4 | |
| FRDTDAEFVDIDGKS | 371 | Q8N0V4 | |
| DEAGTEAAAATSFAI | 371 | P29622 | |
| DKDASIVGFFDDSFS | 151 | P30101 | |
| DDSFSEAHSEFLKAA | 161 | P30101 | |
| SKGSFAGIEDDADEA | 531 | Q8IY81 | |
| EEKSFFSEGCFSEED | 381 | Q8TE82 | |
| EGVSDFFSTSEKEAS | 1571 | Q9P2P6 | |
| KFSDEGDSDSALDSV | 926 | Q96QB1 | |
| TKTSRGEFDSSEFEV | 56 | Q9UNH6 | |
| AFDEAKADFSGMSTE | 291 | P50452 | |
| VEDSTDFFKSGAASV | 341 | O75891 | |
| EDGDGAVSFVEFTKS | 166 | O43745 | |
| DFTATDLSEFAAKAA | 26 | P42765 | |
| FAFKKDTGDTRESSS | 336 | O60701 | |
| GKDFADASASKDSAT | 556 | Q86UP3 | |
| TEAATGSSADFVKDL | 1861 | Q96RL7 | |
| SDDDEFCESVKGASV | 1506 | Q13009 | |
| FSSDTDFEDIEGKNQ | 21 | Q8N3U4 | |
| SEDSDSGDDFFIGKV | 276 | Q8NEF9 | |
| VAVADFEGDKDTSSF | 856 | A1X283 | |
| FEGDKDTSSFQEGTV | 861 | A1X283 | |
| VEESSKSDFSEFGAK | 1071 | Q5VZP5 | |
| VLEGKFSNDDSSSYD | 636 | Q86X10 | |
| IETKEGSEFSFSDGE | 326 | Q9BVS4 | |
| GSEFSFSDGEVAEKA | 331 | Q9BVS4 | |
| AIDFEISGDFASGDF | 381 | Q9BQ16 | |
| AEFGEKDSSKTFSAQ | 266 | Q9Y2K1 | |
| SGESSVFSESGKDFL | 166 | E7ETH6 | |
| EADLFDSGDIFSTGT | 1126 | Q641Q2 | |
| TSAFDFSDEAGDEGL | 26 | O14863 | |
| SGELAAASGKFSDDF | 1266 | Q9Y4G6 | |
| AASGKFSDDFDEFLD | 1271 | Q9Y4G6 | |
| DFTFVSSADAEDLSG | 16 | Q9BSR8 | |
| FASSGFQEDKSLSDV | 966 | P17948 | |
| EFGVAALEKTFDNST | 526 | Q9C0B0 | |
| DVVDGADTFDSSFFS | 281 | Q6PJF5 | |
| DDEIDFKETGFSQDS | 526 | Q5H9R7 | |
| SLASDFGKDDSLFGS | 31 | O14544 | |
| VSEKSDADGSSFEEA | 861 | Q6ZSZ6 | |
| SAFGASDDDLDATKE | 186 | O95365 | |
| FDAQASKINDDDSFT | 36 | Q9NY65 | |
| SGESSVFSESGKDFL | 166 | B7Z6K7 | |
| SGASSFDDTNEKFYD | 636 | O75132 |